Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.

Lung cancer (Amsterdam, Netherlands) - 1 Jul 2012

Lee Jin Gu, Kim Sewha, Shim Hyo Sup

Abstract excerpt

INTRODUCTION: Napsin A is regarded as a marker of lung adenocarcinoma. However, no comprehensive analyses of napsin A-positive lung ADCs or the prognostic significance of napsin A expression have been reported to date. METHODS: 110 primary lung adenocarcinoma cases were analyzed for clinicopathologic parameters, including overall survival, stage, histology, napsin A and TTF-1 expression, EGFR mutation, and ALK...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung
Share to Aspartic Acid Endopeptidases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Tumor Burden

Source

Identifiers

PMID: 22418245
DOI: 10.1016/j.lungcan.2012.02.013

Genes

EGFR
ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.PMID 22418245Read ↗

Effect of Napsin A and Circulating Tumor Cells with Mesenchymal Phenotype in Lung AdenocarcinomaSemantic proximity Read ↗

Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.Semantic proximity Read ↗

Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.Semantic proximity Read ↗

Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype.Semantic proximity Read ↗

Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.Semantic proximity Read ↗

CDX-2 Expression in Primary Lung Adenocarcinoma.Semantic proximity Read ↗

Pulmonary enteric adenocarcinoma: an overview.Semantic proximity Read ↗

Immunohistochemistry Profile Predicts EGFR Mutation Status in Lung Adenocarcinoma.Semantic proximity Read ↗

The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.Semantic proximity Read ↗

Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.Semantic proximity Read ↗

ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.Semantic proximity Read ↗

Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.